The risk of chronic kidney disease development in adult patients with chronic hypoparathyroidism treated with rhPTH(1-84): A retrospective cohort study.

Lars RejnmarkOlulade AyodeleAngela LaxFan MuElyse SwallowElvira O Gosmanova

Published in: Clinical endocrinology (2022)

Patients with chronic hypoparathyroidism treated with rhPTH(1-84) in long-term clinical trials had a significantly lower risk of developing CKD compared with patients in a historical control cohort not treated with rhPTH(1-84).

Keyphrases

chronic kidney disease
end stage renal disease
newly diagnosed
clinical trial
peritoneal dialysis
ejection fraction
prognostic factors
patient reported
phase ii